Answers are grounded in this paper and cite their sources.
This computational study explores drug candidates derived from pleconaril for their potential to inhibit Coxsackievirus B3.
In the light of the serious diseases attributed to it, there is an urgent and inescapable need to hunt for antiviral medications for Coxsackievirus B3 (CVB3).
No takes yet. Share an insight, caveat, or question.
Moukhliss et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: